ConductScience.org, home

Paper4086243

Human pharmacokinetics of esorubicin (4'-deoxydoxorubicin).

Dodion P and 5 others. Invest New Drugs, 1985. Cited by 5 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Human pharmacokinetics of esorubicin (4'-deoxydoxorubicin). Papers, record 4086243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4086243

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Human pharmacokinetics of esorubicin (4'-deoxydoxorubicin).
PubMed
Journal
Invest New Drugs
PubMed
Year
1985
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.32
iCite
Revised in PubMed
2019-10-22
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dodion PP
2Davis TAT A
3Rozencweig MM
4Crespeigne NN
5Kenis YY
6Bachur NRN R

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
DoxorubicinMajor topic
Bone Marrow
Humans
Kinetics

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17296751Fluorescence assays and pharmacokinetic studies of 4'-deoxydoxorubicin and doxorubicin in organs of mice bearing solid tumors.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/7296751PubMed
2496103Risk factors for doxorubicin-induced congestive heart failure.Ann Intern Med1979https://conductscience.org/library/papers/496103PubMed
37017406The anthracycline antineoplastic drugs.N Engl J Med1981https://conductscience.org/library/papers/7017406PubMed
46104578Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography.Drug Metab Dispos1980https://conductscience.org/library/papers/6104578PubMed
56889513Plasma concentrations of carminomycin and carminomycinol in man, measured by high pressure liquid chromatography.Eur J Cancer Clin Oncol1982https://conductscience.org/library/papers/6889513PubMed
66850648Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols.Cancer Res1983https://conductscience.org/library/papers/6850648PubMed
76511235Phase I study with 4'-deoxydoxorubicin.Invest New Drugs1984https://conductscience.org/library/papers/6511235PubMed
83405Adriamycin metabolism in man. Evidence from urinary metabolites.Drug Metab Dispos1976https://conductscience.org/library/papers/3405PubMed
96955010Clinical pharmacology of daunorubicin.Cancer Treat Rep1981https://conductscience.org/library/papers/6955010PubMed
10626965Comparative mammalian metabolism of adriamycin and daunorubicin.Cancer Res1978https://conductscience.org/library/papers/626965PubMed
116683178Antitumor activity in mice of 4'-deoxydoxorubicin in comparison with doxorubicin.Eur J Cancer Clin Oncol1983https://conductscience.org/library/papers/6683178PubMed
126470753Phase I trial of esorubicin (4'deoxydoxorubicin).J Clin Oncol1984https://conductscience.org/library/papers/6470753PubMed
13527325Mlab--a mathematical modeling tool.Comput Programs Biomed1979https://conductscience.org/library/papers/527325PubMed
146271847Initial observations on the effects of delta 9-tetrahydrocannabinol on the plasma pharmacokinetics of cyclophosphamide and doxorubicin.J Clin Pharmacol1981https://conductscience.org/library/papers/6271847PubMed
156831625Time dependency of adriamycin and adriamycinol kinetics.Cancer Chemother Pharmacol1983https://conductscience.org/library/papers/6831625PubMed
16856462Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function.Cancer Res1977https://conductscience.org/library/papers/856462PubMed
177438099New doxorubicin analogs active against doxorubicin-resistant colon tumor xenografts in the nude mouse.Cancer Res1980https://conductscience.org/library/papers/7438099PubMed
18915587Synthetic approaches to adriamycin. 2. Degradation of daunorubicin to a nonasymmetric tetracyclic ketone and refunctionalization of the A ring to adriamycin.J Org Chem1977https://conductscience.org/library/papers/915587PubMed
196678877Phase I trial with 4'-deoxydoxorubicin (esorubicin).Invest New Drugs1983https://conductscience.org/library/papers/6678877PubMed

Download CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
3410662Use of human neuroblastoma continuous cell lines for in vitro drug sensitivity screening.Invest New Drugs1988https://conductscience.org/library/papers/3410662PubMed
2948729Anthracycline analogs: the past, present, and future.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/2948729PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4086243

GET https://conductscience.org/api/papers/v1/4086243/authors